Forschungsschwerpunkte

Near normal intraocular pressure cataract surgery in patients with diabetic retinopathy using active anterior chamber pressure sensing and regulation - a randomized controlled comparative clinical trial

Katarakt OP mit Diabetes

laufend

Evaluation of diagnostic effectiveness and reliability of a telemedical examination with Occyo One vs traditional slit lamp-based examination after cataract surgery

Katarakt OP 

beendet

Long-term need of Ranibizumab injections with or without early targeted peripheral laser photocoagulation for treatment of macular edema due to central retinal vein occlusion
CoRaLa II trial

Makular Ödem

laufend

A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants with Thyroid Eye Disease

Endokrine Orbitopathie / Thyroid Eye Diesease

beendet

A randomized, double masked, multicenter, 3-arm pivotal Phase 2/3 Studi to Evaluate the Efficacy and sefty of intravitreal Eye103 compared with intravitreal Ranibizumab (0,5mg) in Participants with Diabetic Macular Edema

Diabetisches Makula Ödem

laufend

Real-world, long-term data collection to gain clinical insights into faricimab
(FAREAL study)

Diabetisches Makula Ödem / altersbedingte Makuladegeneration

laufend

A phase IIIb, multicenter, single-arm study assessing the effectiveness, safety and patient-reported outcomes of a 36-week refill exchange regimen for the port delivery system with ranibizumab in patients with neovascular age-related macular degeneration
(SIGHTSPIRE study)

altersbedingte Makuladegeneration

laufend

Neovascular Age-Related Macular Degeneration (nAMD): A Randomized Controlled, Partially Masked, Phase 3b Study to Assess the Injection Burden, Efficacy, Safety, and Long-Term Preservation of Visual Acuity in a Real-World Context (ACHIEVE-STUDY)

altersbedingte Makuladegeneration

laufend

A randomized, phase 3, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma
(OptimUM-10)

Uveal Melanom

StartUp

Europäisches Register für Frühgeborenen Retinopahti (EUROP)

Frühgeborenen Retinopathie

laufend